摘要
血管紧张肽Ⅱ受体1拮抗药(ARB)是一类第一线的降压药物,具有疗效显著、不良反应轻等优点。本文根据已发表的文章,对7种ARB在起始剂量和推荐剂量下的降压疗效进行比较。研究表明,奥美沙坦、替米沙坦等t1/2较长的ARB具有较强的降压作用。
Agiotensin Ⅱ receptor 1 antagonist is a first-line antihypertensive agent, and has the advantage of good efficacy and less adverse reaction. According to the published paper, the antihypertensive efficacy of 7 angiotensin Ⅱ receptor 1 antagonists in starting dosage and recommended dosage was compared in this paper. Some studies showed that some newer, longer half-life angiotensin Ⅱ reeeptor 1 antagonist (such as olmesartan and telmisartan) had stronger antihypertensive effieacy.
出处
《中国新药与临床杂志》
CAS
CSCD
北大核心
2009年第11期810-813,共4页
Chinese Journal of New Drugs and Clinical Remedies